SCHEMBL6137082

SCHEMBL6137082

CC1=C(C#N)C(c2cccc(F)c2)NC(=O)N1C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.50
ALDH1A1 P00352 3/20 0.49
LMNA P02545 2/20 0.47
RECQL P46063 1/20 0.46
CYP2C9 P11712 2/20 0.42
ELANE P08246 1/20 0.42
MAPT P10636 2/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C19 P33261 1/20 0.42
PKM P14618 1/20 0.41
KMT2A Q03164 5/20 0.39
MEN1 O00255 4/20 0.39
IDO1 P14902 1/20 0.39
HCRTR1 O43613 1/20 0.39
GPR55 Q9Y2T6 1/20 0.39
PABPC1 P11940 2/20 0.37
APOBEC3A P31941 1/20 0.37
APOBEC3G Q9HC16 1/20 0.37
IDE P14735 1/20 0.36
HTR7 P34969 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6609236 0.87 ELANE (0.45) TDP1CYP2C9ELANE
SCHEMBL6137166 0.86 KMT2A (0.45) TDP1ALDH1A1LMNACYP2C9ELANE
SCHEMBL6137365 0.86 ELANE (0.40) TDP1ALDH1A1LMNACYP2C9ELANE
SCHEMBL6137118 0.86 HTT (0.43) TDP1ALDH1A1LMNACYP2C9ELANE
SCHEMBL6608283 0.86 ELANE (0.40) TDP1ALDH1A1LMNARECQLCYP2C9
SCHEMBL6608090 0.86 MAPK1 (0.44) TDP1ALDH1A1LMNARECQLCYP2C9
SCHEMBL6137178 0.85 ELANE (0.43) TDP1ALDH1A1CYP2C9ELANEMAPT
SCHEMBL6137331 0.85 ELANE (0.57) ALDH1A1LMNARECQLCYP2C9ELANE
SCHEMBL6609319 0.84 ALDH1A1 (0.46) ALDH1A1CYP2C9ELANEMAPTNR3C2
SCHEMBL6137233 0.84 ELANE (0.39) TDP1ALDH1A1LMNARECQLCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1373221-A4 NOVEL CYANO-SUBSTITUTED DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USE TO TREAT DISEASES BRISTOL MYERS SQUIBB CO (US) 2004-09-29 EP claimed
EP-1373221-A2 NOVEL CYANO-SUBSTITUTED DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USE TO TREAT DISEASES Bristol-Myers Squibb Company (US) 2004-01-02 EP claimed
WO-2002079149-A2 NOVEL CYANO-SUBSTITUTED DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USE TO TREAT DISEASES BRISTOL-MYERS SQUIBB COMPANY (US) 2002-10-10 WO claimed
EP-1372657-A4 A METHOD OF TREATING PROLIFERATIVE DISEASES USING EG5 INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2005-11-09 EP disclosed
EP-1373223-A4 CYANO-SUBSTITUTED DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USE TO TREAT DISEASES BRISTOL MYERS SQUIBB CO (US) 2004-09-29 EP disclosed
EP-1372657-A2 A METHOD OF TREATING PROLIFERATIVE DISEASES USING EG5 INHIBITORS Bristol-Myers Squibb Company (US) 2004-01-02 EP disclosed
EP-1373223-A1 CYANO-SUBSTITUTED DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USE TO TREAT DISEASES Bristol-Myers Squibb Company (US) 2004-01-02 EP disclosed
WO-2002079169-A1 CYANO-SUBSTITUTED DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USE TO TREAT DISEASES BRISTOL-MYERS SQUIBB COMPANY (US) 2002-10-10 WO disclosed
WO-2002078639-A2 A METHOD OF TREATING PROLIFERATIVE DISEASES USING EG5 INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2002-10-10 WO disclosed